Het testen van de waarde van een nieuwe strategische benadering en de kosteneffectiviteit ervan om de slechte resultaten bij cardiogene shock te verbeteren. KU Leuven
Heart attacks are common and can leave survivors suffering cardiogenic shock (CGS), with its extremely high risk of early death (42% versus 4% for non-CGS) and high incidence of chronic heart failure, with its associated socio-economic disease burden (ill-health, recurrent heart failure admissions, no return to full time activities, need for expensive therapeutic devices and life-long drugs). Outcomes from CGS are even worse in, females, the ...